Harman Patil (Editor)

Ruplizumab

Updated on
Edit
Like
Comment
Share on FacebookTweet on TwitterShare on LinkedInShare on Reddit
Type
  
Whole antibody

Target
  
ATC code
  
none

Source
  
Humanized (from mouse)

Trade names
  
Antova

CAS Number
  
220651-94-5

Ruplizumab (trade name Antova) is a humanized monoclonal antibody intended for the treatment of rheumatic diseases like systemic lupus erythematosus and lupus nephritis. A study showed that the drug was associated with life-threatening thromboembolisms, while another study only found thrombocytopenia.

References

Ruplizumab Wikipedia


Similar Topics